Literature DB >> 9160092

The effects of cyclosporin A on V(D)J recombination activity.

U Döbbeling1.   

Abstract

V(D)J recombination is up-regulated by the protein kinase A (PKA) pathway and down-regulated by the protein kinase C (PKC) and Ca2+ pathways. When activators of the PKA and PKC pathways or the PKA and Ca2+ pathways are given at the same time, a strong reduction of the PKA effect is observed. The V(D)J recombination suppressing effect of elevated intracellular Ca2+ levels, but not that of the PKC pathway, can be abrogated by the addition of the calcineurin inhibitor cyclosporin A (CsA), indicating that the effect of Ca2+ is mediated by calcineurin. This effect is observed in a pre B cell line as well as in the V(D)J recombination competent fibroblast cell line L4, indicating that the mechanisms of the cross talk between different signalling pathways are basically the same in both cell types. In the absence of Ca2+ mobilizer CsA increases the V(D)J recombination rate in pre B cells but not in L4 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160092     DOI: 10.1046/j.1365-3083.1997.d01-426.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents.

Authors:  O Jirapongsananuruk; D Y Leung
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits.

Authors:  Nathalie Chami; Ming-Huei Chen; Andrew J Slater; John D Eicher; Evangelos Evangelou; Salman M Tajuddin; Latisha Love-Gregory; Tim Kacprowski; Ursula M Schick; Akihiro Nomura; Ayush Giri; Samuel Lessard; Jennifer A Brody; Claudia Schurmann; Nathan Pankratz; Lisa R Yanek; Ani Manichaikul; Raha Pazoki; Evelin Mihailov; W David Hill; Laura M Raffield; Amber Burt; Traci M Bartz; Diane M Becker; Lewis C Becker; Eric Boerwinkle; Jette Bork-Jensen; Erwin P Bottinger; Michelle L O'Donoghue; David R Crosslin; Simon de Denus; Marie-Pierre Dubé; Paul Elliott; Gunnar Engström; Michele K Evans; James S Floyd; Myriam Fornage; He Gao; Andreas Greinacher; Vilmundur Gudnason; Torben Hansen; Tamara B Harris; Caroline Hayward; Jussi Hernesniemi; Heather M Highland; Joel N Hirschhorn; Albert Hofman; Marguerite R Irvin; Mika Kähönen; Ethan Lange; Lenore J Launer; Terho Lehtimäki; Jin Li; David C M Liewald; Allan Linneberg; Yongmei Liu; Yingchang Lu; Leo-Pekka Lyytikäinen; Reedik Mägi; Rasika A Mathias; Olle Melander; Andres Metspalu; Nina Mononen; Mike A Nalls; Deborah A Nickerson; Kjell Nikus; Chris J O'Donnell; Marju Orho-Melander; Oluf Pedersen; Astrid Petersmann; Linda Polfus; Bruce M Psaty; Olli T Raitakari; Emma Raitoharju; Melissa Richard; Kenneth M Rice; Fernando Rivadeneira; Jerome I Rotter; Frank Schmidt; Albert Vernon Smith; John M Starr; Kent D Taylor; Alexander Teumer; Betina H Thuesen; Eric S Torstenson; Russell P Tracy; Ioanna Tzoulaki; Neil A Zakai; Caterina Vacchi-Suzzi; Cornelia M van Duijn; Frank J A van Rooij; Mary Cushman; Ian J Deary; Digna R Velez Edwards; Anne-Claire Vergnaud; Lars Wallentin; Dawn M Waterworth; Harvey D White; James G Wilson; Alan B Zonderman; Sekar Kathiresan; Niels Grarup; Tõnu Esko; Ruth J F Loos; Leslie A Lange; Nauder Faraday; Nada A Abumrad; Todd L Edwards; Santhi K Ganesh; Paul L Auer; Andrew D Johnson; Alexander P Reiner; Guillaume Lettre
Journal:  Am J Hum Genet       Date:  2016-06-23       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.